Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted April 16, 2014
Weight Loss Supplements Found To Contain Prescription Antidepressant and Other Drugs
- Adipotrim XT was found to contain fluoxetine.
Fluoxetine is an FDA approved selective serotonin reuptake inhibitor (SSRI) drug prescribed to treat depression, anxiety, and other conditions. SSRI drugs are associated with serious side effects including suicidal thinking, abnormal bleeding, and seizures, and can interact with other common medications such as aspirin and ibuprofen, which can cause ventricular arrhythmia or sudden death.
One lot of Adipotrim XT was recalled in 2013 after it was found to contain undeclared fluoxetine.
- Burn 7 was found to contain sibutramine ad phenolphthalein.
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective."
One lot of Burn 7 was recalled in 2013 after it was found to contain sibutramine.
- Reductrol Fat Burner Formula was found to contain acetaminophen and phenolphthalein (see information above).
Acetaminophen is an over-the-counter (OTC) pain reliever that can cause a rare, but potentially fatal skin reaction, and, in large doses, liver damage.
In addition, statements made on the company's website about Adipotrim XT, Burn 7, Reductrol Fat Burner Formula, along with several other Deseo Rebajar products, including Adipocleanse, Adipocleanse XT, Lipozene 1500 mg, and Slim Patch 1, were found to be drug claims.
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
(See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.)
See Related Warnings:
To read the FDA's warning, use the link below.